S 1140 · 116th Congress 2019–2021, ended

Protecting Access to Biosimilars Act of 2019

Fact sheet

Latest action · Apr 11, 2019 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedApr 11, 2019
  2. Passed SenateNot reached
  3. Passed HouseNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Protecting Access to Biosimilars Act of 2019

This bill excludes biological products that were initially licensed under the Federal Food, Drug, and Cosmetic Act (FD&C Act) (e.g., insulin) from the exclusivity protections that delay the licensure of biosimilar products under the Public Health Service Act (PHS Act). (The Biologics Price Competition and Innovation Act of 2009 generally requires that biological products approved under the FD&C Act are treated as though they were approved under the PHS Act through March 23, 2020.)

Cosponsors 2

Members who signed on, in the order they did. Signatures ran from Apr 11, 2019 to May 7, 2019, with 1 there on the day it was introduced.

SeatCosponsorSigned on
R-LABill CassidyOriginalApr 11, 2019
R-NDKevin CramerMay 7, 2019

Actions 2

Everything that happened, newest first.

  1. Apr 11, 2019Introduced in Senate
  2. Apr 11, 2019Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Related bills 2

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 1895Lower Health Care Costs ActRelated billJul 8, 2019
HR 2011Protecting Access to Biosimilars Act of 2019Related billApr 2, 2019

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Apr 11, 2019Introduced in Senate

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.